Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Back to Test Catalogue
Test ID: HEPFONDA

Heparin – Fondaparinux, Plasma

Test Overview

Method

Chromogenic Assay

Analytical Platform

STA-R Analyzer

Result Included

Heparin - Fondaparinux

Aliases/Synonyms

Arixtra

Specimen

Specimen Type

Plasma (Na Citrate)

Volume

Sample Volume

1 mL

Collection & Handling

Handling Information

Prepare platelet poor plasma. Separate and freeze immediately. Store and send frozen.

Rejection Criteria

Criteria Specification
Specimen Not frozen

Performance & Interpretation

Turnaround Time

3 days

Results

Name
Units
Reference Range
Conversion
  1. Heparin - Fondaparinux
    U/mL
    A therapeutic range for Fondaparinux has not been established. Average peak, steady-state levels (2 - 3 hours post-dose) of approximately 1.02-1.07 IU anti-Xa activity/mL have been reported for patients given therapeutic doses of Fondaparinux for symptomatic DVT/PE.

Referral Location

Canada

Interface & Setup

HL7 Interface Codes

Order Code Result Name Result Codes Units
HEPFONA HEP 10A - FONDA 28134 U/mL

Test Version

Last Updated

2023-06-08